GlassScriptPhysician profile
Rogena K Johnson
NPI 1013059245
$920.63
in general payments reported to CMS, 2019-2025
20 companies · $255 in 2025
The $255 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.55 · 2020: $10.09 · 2021: $192 · 2022: $137 · 2023: $164 · 2024: $151 · 2025: $255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $570.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $570.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $268.16 | 2021-2025 | |
| Novo Nordisk INC | $155.85 | 2022-2025 | Ozempic, Rybelsus |
| Amgen INC. | $80.40 | 2022-2025 | Repatha, Otezla, Evenity |
| Lilly USA, LLC | $70.12 | 2021-2022 | |
| Neurocrine Biosciences, INC. | $37.97 | 2021-2023 | Ingrezza |
| Astellas Pharma US INC | $36.81 | 2024-2025 | Veozah |
| Paratek Pharmaceuticals, INC. | $33.83 | 2023-2025 | Nuzyra |
| Gilead Sciences, INC. | $33.46 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $26.22 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $23.97 | 2025 | Breztri |
| Otsuka America Pharmaceutical, INC. | $23.94 | 2025 | Rexulti |
| Pharmacosmos Therapeutics INC. | $21.71 | 2025 | Monoferric |
| Exact Sciences Corporation | $16.91 | 2023 | Cologuard Collection Kit |
| Sanofi Pasteur INC. | $16.58 | 2021 | |
| Abbott Laboratories | $14.49 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $13.93 | 2025 | |
| Sunovion Pharmaceuticals INC. | $12.65 | 2021 | |
| Lundbeck LLC | $11.99 | 2021 | |
| Merck Sharp & Dohme LLC | $11.55 | 2019 | |
| Veran Medical Technologies, INC. | $10.09 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rogena Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.